Syndicate

Latest KFF Health News Stories

A Crisis With Little Data: States Begin To Count Drug-Dependent Babies

KFF Health News Original

Getting good information is critical to figure out where resources need to go to treat babies dependent on drugs. Pennsylvania relies on old statistics and incomplete data, but that may be changing.

Pregnant And Addicted: The Tough Road To A Healthy Family

KFF Health News Original

Guilt still haunts a new mother who was addicted to opioids when she got pregnant. Once she was ready to ask for help, treatment programs that could handle her complicated pregnancy were hard to find.

When Medicare Advantage Drops Doctors, Some Members Can Switch Plans

KFF Health News Original

In the past eight months, Medicare officials have quietly granted the special enrollment periods to more than 15,000 Medicare Advantage members in seven states, the District of Columbia and Puerto Rico.

Contratistas Agrícolas Se Resisten A Requisitos Del Obamacare

KFF Health News Original

La ley federal de salud está poniendo a los agricultores en una situación difícil. Muchos contratistas que suministran trabajadores tienen que ofrecer cobertura de salud. El seguro es costoso, y los contratistas se preocupan sobre las consecuencias para la inmigración.

Pharmaceutical Company Has Hiked Price On Aid-In-Dying Drug

KFF Health News Original

Valeant Pharmaceuticals, the company that makes Seconal, the drug most commonly used in prescribed for terminally ill patients who want to end their lives, physician-assisted suicide, has doubled the price to more than $3,000.

Tiny Opioid Patients Need Help Easing Into Life

KFF Health News Original

More babies are being born dependent on opioids. The good news is they can safely be weaned from the drug. But there’s little research on which medical treatment is best, or its long-term effects.

Device Maker Olympus Hiked Prices For Scopes As Superbug Infections Spread

KFF Health News Original

The device manufacturer had a close relationship with Ronald Reagan UCLA Medical Center in Los Angeles — until its scopes were linked to infections and the company raised the price for new ones by 28 percent.